Impaired binding of drugs and endogenous ligands in renal diseases.

作者信息

Gulyassy P F, Depner T A

出版信息

Am J Kidney Dis. 1983 May;2(6):578-601. doi: 10.1016/s0272-6386(83)80038-9.

DOI:10.1016/s0272-6386(83)80038-9

PMID:6342372

Abstract

摘要

相似文献

Impaired binding of drugs and endogenous ligands in renal diseases.

Am J Kidney Dis. 1983 May;2(6):578-601. doi: 10.1016/s0272-6386(83)80038-9.

Role of alpha-1 acid glycoprotein, albumin, and nonesterified fatty acids in serum binding of apazone and warfarin.

Clin Pharmacol Ther. 1986 Jun;39(6):683-9. doi: 10.1038/clpt.1986.119.

Drug-binding properties of rat alpha 1-foetoprotein. Binding of warfarin, phenylbutazone, azapropazone, diazepam, digitoxin and cholic acid.

Biochem J. 1984 Jul 15;221(2):401-6. doi: 10.1042/bj2210401.

Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.

Nephrol Dial Transplant. 2008 Jul;23(7):2304-10. doi: 10.1093/ndt/gfn002. Epub 2008 Apr 5.

Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands.

Mol Pharmacol. 1988 Aug;34(2):160-71.

High-affinity binding of ethacrynic acid is mediated by the two most important drug binding sites of human serum albumin.

Pharmacology. 1986;32(4):208-13. doi: 10.1159/000138171.

The location of drug binding sites in human serum albumin.

Biochem Pharmacol. 1981 Apr 1;30(7):687-92. doi: 10.1016/0006-2952(81)90151-9.

The binding capacity of albumin and renal disease.

J Pharmacol Exp Ther. 1974 Nov;191(2):318-23.

[Binding and transport of substances by serum albumin].

Vopr Med Khim. 1973;19(4):339-50.

A re-evaluation of the HSA-piroxicam interaction.

Eur J Drug Metab Pharmacokinet. 1990 Oct-Dec;15(4):303-7. doi: 10.1007/BF03190219.

引用本文的文献

Antimicrobial dosing in critically ill patients with sepsis-induced acute kidney injury.

Indian J Crit Care Med. 2015 Feb;19(2):99-108. doi: 10.4103/0972-5229.151018.

Can oral therapy reduce uremic toxins?

Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1513-5. doi: 10.2215/CJN.07330714. Epub 2014 Aug 21.

Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients.

Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1603-10. doi: 10.2215/CJN.00490114. Epub 2014 Aug 21.

Prominent accumulation in hemodialysis patients of solutes normally cleared by tubular secretion.

J Am Soc Nephrol. 2014 Mar;25(3):615-22. doi: 10.1681/ASN.2013060597. Epub 2013 Nov 14.

Pharmacokinetics of etoposide in rats with uranyl nitrate (UN)-induced acute renal failure (ARF): optimization of the duration of UN dosing.

Eur J Drug Metab Pharmacokinet. 2007 Oct-Dec;32(4):189-96. doi: 10.1007/BF03191003.

Quinine pharmacokinetics in chronic haemodialysis patients.

Br J Clin Pharmacol. 2002 Dec;54(6):604-9. doi: 10.1046/j.1365-2125.2002.01680.x.

Production of antiserum for sensitive enzyme-linked immunosorbent assay of 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid by chemiluminescence.

Lipids. 1998 Jul;33(7):733-6. doi: 10.1007/s11745-998-0264-0.

Clinical pharmacokinetics during continuous haemofiltration.

Clin Pharmacokinet. 1994 Jun;26(6):457-71. doi: 10.2165/00003088-199426060-00004.

Preserving renal function in surgical patients.

West J Med. 1987 Mar;146(3):316-21.

Drug removal by continuous arteriovenous haemofiltration. A review of the evidence in poisoned patients.

Med Toxicol Adverse Drug Exp. 1988 Sep-Oct;3(5):341-9. doi: 10.1007/BF03259889.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验